Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net income (loss)	$ 22,320	$ (513)	$ 9,300
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	30,600	24,063	13,295
Deferred income taxes	413	(2,981)	(660)
Stock-based compensation	9,390	6,736	3,136
Non-cash lease expense	1,789	2,135	2,497
Amortization of contract asset	2,999	2,058	669
Provision for expected credit losses	88	268	106
Change in operating assets and liabilities
Accounts and other receivables	(8,672)	(24,287)	(14,736)
Prepaid expenses and other current and long-term assets	(1,184)	1,211	1,346
Accounts payable	6,017	4,766	7,380
Accrued liabilities	6,288	3,400	(44)
Operating lease liabilities	(1,817)	(1,832)	(2,443)
Contract liabilities	(361)	3,299	474
Income taxes receivable, net of payable	958	1,544	(827)
Net cash provided by operating activities	68,828	19,867	19,493
Cash flows from investing activities
Business combinations, net of cash and restricted cash acquired	0	(3,260)	(57,400)
Other intangible assets acquired	0	(280)	(130)
Purchases of property and equipment	(600)	(1,257)	(979)
Capitalized internal-use software development costs	(33,699)	(29,763)	(19,300)
Net cash used in investing activities	(34,299)	(34,560)	(77,809)
Cash flows from financing activities
Proceeds from initial public offering, net of underwriter's discounts and commissions	0	0	224,595
Proceeds from private placement	0	0	50,000
Proceeds from repayment of related party loan	0	0	813
Proceeds from exercise of stock-based awards	616	1,490	315
Financial institution funds in-transit	0	(33,443)	1,984
Payments of deferred offering costs	0	0	(1,961)
Payments on other financing obligations	(1,709)	(5,062)	(4,562)
Payments on finance leases	(102)	(268)	(272)
Net cash (used in) provided by financing activities	(1,195)	(37,283)	213,487
Effect of exchange rate changes on Cash and cash equivalents and Restricted cash	176	(168)	(8)
Net increase in cash, cash equivalents and Restricted cash	33,510	(52,144)	155,163
Cash and cash equivalents and Restricted cash beginning of period	149,685	201,829	46,666
Cash and cash equivalents and Restricted cash end of period	183,195	149,685	201,829
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net of refunds	1,398	672	2,487
Non-cash investing activities:
Property and equipment purchases in accounts payable		81	268
Business acquisition liability in accrued liabilities and finance leases and other finance obligations, net of current portion		740	813
Non-cash financing activities:
Prepaid insurance funded through short-term borrowings		4,625	5,756
Issuance of warrant and change in estimate of warrants expected to vest		3,524	4,802
Cash and Cash Equivalents [Member]
Cash flows from financing activities
Cash and cash equivalents and Restricted cash beginning of period	147,334	168,386	46,666
Cash and cash equivalents and Restricted cash end of period	179,361	147,334	168,386
Restricted Cash [Member]
Cash flows from financing activities
Cash and cash equivalents and Restricted cash beginning of period	2,351	0	0
Cash and cash equivalents and Restricted cash end of period	3,834	2,351	0
Restricted Funds Held For Financial Institutions [Member]
Cash flows from financing activities
Cash and cash equivalents and Restricted cash beginning of period	0	33,443	0
Cash and cash equivalents and Restricted cash end of period	0	0	33,443
Series A Preferred Stock [Member]
Cash flows from financing activities
Redemption of Series A preferred stock	0	0	(23,013)
Payment of dividends on Series A preferred stock	$ 0	$ 0	$ (34,412)
Class A Common Stock [Member]
Non-cash investing activities:
Issuance of Class A common stock for acquisitions, Shares			66,229